Clinical trial
Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
NCT02591173 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- February 29, 2016
- Completion date
- July 31, 2020
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autonomic nervous system disorders, orthostatic hypotension, dysautonomic, pure autonomic failure, shy-drager syndrome